ARCHIVES

FDA Approves Lilly’s Alimta For Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 27 No. 8 | August 27, 2004

Download PDF Visit The Full Archive

Related Articles

Trial Needed Of PSA To Determine Patients To Test, Chabner Says

March 5, 1993

In Brief: AC Committee Picks Seffrin for Executive VP; Charles Wilson Names to NCAB; 5 Leave Board

May 15, 1992

Flat NIH Budget Threatens Future Of Research, Universities Say.

March 14, 2008

NIH Releases Digestive Diseases Research Plan

May 1, 2009

NCI Advisory Group, Other Cancer Meetings

April 29, 1983

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

September 7, 2012